Generation of CRB1 RP Patient-Derived iPSCs and a CRISPR/Cas9-Mediated Homology-Directed Repair Strategy for the CRB1 c.2480G>T Mutation

Adv Exp Med Biol. 2023:1415:571-576. doi: 10.1007/978-3-031-27681-1_83.

Abstract

Mutations in the Crumbs-homologue-1 (CRB1) gene lead to a spectrum of severe inherited retinal diseases, including retinitis pigmentosa (RP). The establishment of a genotype-phenotype correlation in CRB1 patients has been difficult due to the substantial variability and phenotypic overlap between CRB1-associated diseases. This phenotypic modulation may be due to several factors, including genetic modifiers, deep intronic mutations, isoform diversity, and copy number variations. Induced pluripotent stem cell (iPSC)-derived patient retinal organoids are novel tools that can provide sensitive, quantitative, and scalable phenotypic assays. CRB1 RP patient iPSC-derived retinal organoids have shown reproducible phenotypes compared to healthy retinal organoids. However, having genetically defined iPSC isogenic controls that take into account potential phenotypic modulation is crucial. In this study, we generated iPSC from an early-onset CRB1 patient and developed a correction strategy for the c.2480G>T, p.(Gly827Val) CRB1 mutation using CRISPR/Cas9-mediated homology-directed repair.

Keywords: Crumbs-homologue-1 (CRB1); Gene editing; Homology-directed repair (HDR); Retinitis pigmentosa (RP); iPSC-derived retinal organoids.

MeSH terms

  • CRISPR-Cas Systems / genetics
  • DNA Copy Number Variations
  • Eye Proteins / genetics
  • Humans
  • Induced Pluripotent Stem Cells*
  • Membrane Proteins / genetics
  • Mutation
  • Nerve Tissue Proteins / genetics
  • Retinitis Pigmentosa* / genetics
  • Retinitis Pigmentosa* / therapy

Substances

  • Eye Proteins
  • CRB1 protein, human
  • Membrane Proteins
  • Nerve Tissue Proteins